SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease.
BACKGROUND:SDF1 and its cognate receptors CXCR4 and CXCR7 are involved in myocardial repair and are associated with outcome in cardiovascular patients. Hence, we aimed to investigate clinically significant SDF1 SNPs for their prognostic impact in patients with cardiovascular disease. METHODS AND RES...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5015912?pdf=render |
| _version_ | 1811309841322344448 |
|---|---|
| author | Dominik Rath Elke Schaeffeler Stefan Winter Jens Hewer Karin Müller Michal Droppa Fabian Stimpfle Meinrad Gawaz Matthias Schwab Tobias Geisler |
| author_facet | Dominik Rath Elke Schaeffeler Stefan Winter Jens Hewer Karin Müller Michal Droppa Fabian Stimpfle Meinrad Gawaz Matthias Schwab Tobias Geisler |
| author_sort | Dominik Rath |
| collection | DOAJ |
| description | BACKGROUND:SDF1 and its cognate receptors CXCR4 and CXCR7 are involved in myocardial repair and are associated with outcome in cardiovascular patients. Hence, we aimed to investigate clinically significant SDF1 SNPs for their prognostic impact in patients with cardiovascular disease. METHODS AND RESULTS:Genotyping for selected SDF1 variants (rs1065297, rs2839693, rs1801157, rs266087, rs266085 and rs266089 was performed in patients (n = 872) who underwent percutaneous coronary intervention. Carriers of variant rs2839693 and rs266089 showed significantly higher cumulative event-free survival compared with non-carriers. All other polymorphisms had no relevant influence on outcome. Multivariate Cox regression analysis showed a significant correlation of these SNPs with cardiovascular outcome after inclusion of clinical and prognostic relevant variables (hazard ratio (HR) 0.51 (95% CI 0.30-0.88), p = 0.015 and [HR 0.51 (95% CI 0.30-0.88), p = 0.016, respectively). In addition, multivariate Cox regression with SDF1 haplotypes revealed a significantly reduced risk for the haplotype carrying the minor alleles of rs2839693 and rs266089 (HR 0.47 (95% CI 0.27-0.84), p = 0.011). CONCLUSION:Distinct SDF1 polymorphisms are associated with improved cardiovascular prognosis in CAD patients. Further studies are warranted to validate these results and to better describe the endogenous regeneration potential in carriers of these SNPs. Targeted, genotype guided therapeutic approaches to foster myocardial regeneration and thus cardiovascular prognosis should be evaluated in future. |
| first_indexed | 2024-04-13T09:48:13Z |
| format | Article |
| id | doaj.art-176d6560e0434f53bd4ad95f47ea3597 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-13T09:48:13Z |
| publishDate | 2016-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-176d6560e0434f53bd4ad95f47ea35972022-12-22T02:51:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01119e016193310.1371/journal.pone.0161933SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease.Dominik RathElke SchaeffelerStefan WinterJens HewerKarin MüllerMichal DroppaFabian StimpfleMeinrad GawazMatthias SchwabTobias GeislerBACKGROUND:SDF1 and its cognate receptors CXCR4 and CXCR7 are involved in myocardial repair and are associated with outcome in cardiovascular patients. Hence, we aimed to investigate clinically significant SDF1 SNPs for their prognostic impact in patients with cardiovascular disease. METHODS AND RESULTS:Genotyping for selected SDF1 variants (rs1065297, rs2839693, rs1801157, rs266087, rs266085 and rs266089 was performed in patients (n = 872) who underwent percutaneous coronary intervention. Carriers of variant rs2839693 and rs266089 showed significantly higher cumulative event-free survival compared with non-carriers. All other polymorphisms had no relevant influence on outcome. Multivariate Cox regression analysis showed a significant correlation of these SNPs with cardiovascular outcome after inclusion of clinical and prognostic relevant variables (hazard ratio (HR) 0.51 (95% CI 0.30-0.88), p = 0.015 and [HR 0.51 (95% CI 0.30-0.88), p = 0.016, respectively). In addition, multivariate Cox regression with SDF1 haplotypes revealed a significantly reduced risk for the haplotype carrying the minor alleles of rs2839693 and rs266089 (HR 0.47 (95% CI 0.27-0.84), p = 0.011). CONCLUSION:Distinct SDF1 polymorphisms are associated with improved cardiovascular prognosis in CAD patients. Further studies are warranted to validate these results and to better describe the endogenous regeneration potential in carriers of these SNPs. Targeted, genotype guided therapeutic approaches to foster myocardial regeneration and thus cardiovascular prognosis should be evaluated in future.http://europepmc.org/articles/PMC5015912?pdf=render |
| spellingShingle | Dominik Rath Elke Schaeffeler Stefan Winter Jens Hewer Karin Müller Michal Droppa Fabian Stimpfle Meinrad Gawaz Matthias Schwab Tobias Geisler SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease. PLoS ONE |
| title | SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease. |
| title_full | SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease. |
| title_fullStr | SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease. |
| title_full_unstemmed | SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease. |
| title_short | SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease. |
| title_sort | sdf1 polymorphisms influence outcome in patients with symptomatic cardiovascular disease |
| url | http://europepmc.org/articles/PMC5015912?pdf=render |
| work_keys_str_mv | AT dominikrath sdf1polymorphismsinfluenceoutcomeinpatientswithsymptomaticcardiovasculardisease AT elkeschaeffeler sdf1polymorphismsinfluenceoutcomeinpatientswithsymptomaticcardiovasculardisease AT stefanwinter sdf1polymorphismsinfluenceoutcomeinpatientswithsymptomaticcardiovasculardisease AT jenshewer sdf1polymorphismsinfluenceoutcomeinpatientswithsymptomaticcardiovasculardisease AT karinmuller sdf1polymorphismsinfluenceoutcomeinpatientswithsymptomaticcardiovasculardisease AT michaldroppa sdf1polymorphismsinfluenceoutcomeinpatientswithsymptomaticcardiovasculardisease AT fabianstimpfle sdf1polymorphismsinfluenceoutcomeinpatientswithsymptomaticcardiovasculardisease AT meinradgawaz sdf1polymorphismsinfluenceoutcomeinpatientswithsymptomaticcardiovasculardisease AT matthiasschwab sdf1polymorphismsinfluenceoutcomeinpatientswithsymptomaticcardiovasculardisease AT tobiasgeisler sdf1polymorphismsinfluenceoutcomeinpatientswithsymptomaticcardiovasculardisease |